| 701 |
Cord Tissue |
Allogeneic – Unrelated |
Degenerative and traumatic cartilage damage |
Orthopedics |
2025 |
Experimental Therapy |
Poland |
57,2 |
| 702 |
Cord Tissue |
Allogeneic – Unrelated |
Cerebral Palsy |
Neurology |
2025 |
Experimental Therapy |
Poland |
3,1 |
| 703 |
Cord Tissue |
Allogeneic – Unrelated |
Cerebral Palsy |
Neurology |
2025 |
Experimental Therapy |
Poland |
3,4 |
| 704 |
Cord Tissue |
Allogeneic – Unrelated |
Cerebral Palsy |
Neurology |
2025 |
Experimental Therapy |
Poland |
2,8 |
| 705 |
Cord Tissue |
Allogeneic – Unrelated |
Autism |
Neurology |
2025 |
Experimental Therapy |
Poland |
5,9 |
| 706 |
Cord Tissue |
Allogeneic – Unrelated |
Cerebral Palsy |
Neurology |
2025 |
Experimental Therapy |
Poland |
11,9 |
| 707 |
Cord Tissue |
Allogeneic – Unrelated |
Degenerative and traumatic cartilage damage |
Orthopedics |
2025 |
Experimental Therapy |
Poland |
54,2 |
| 708 |
Cord Tissue |
Allogeneic – Unrelated |
Degenerative and traumatic cartilage damage |
Orthopedics |
2025 |
Experimental Therapy |
Poland |
78,4 |
| 709 |
Cord Tissue |
Allogeneic – Unrelated |
Autism |
Neurology |
2025 |
Experimental Therapy |
Poland |
6,8 |
| 710 |
Cord Tissue |
Allogeneic – Unrelated |
Degenerative and traumatic cartilage damage |
Orthopedics |
2025 |
Experimental Therapy |
Poland |
58,2 |
| 711 |
Cord Tissue |
Autologous |
Autism |
Neurology |
2025 |
Experimental Therapy |
Romania |
5 |
| 712 |
Cord Tissue |
Allogeneic – Related |
Autism |
Neurology |
2025 |
Experimental Therapy |
Romania |
5 |
| 713 |
Cord Tissue |
Allogeneic – Unrelated |
Autism |
Neurology |
2025 |
Experimental Therapy |
Poland |
4,1 |
| 714 |
Cord Tissue |
Allogeneic – Unrelated |
Cerebral Palsy |
Neurology |
2025 |
Experimental Therapy |
Poland |
7,9 |
| 715 |
Cord Tissue |
Allogeneic – Unrelated |
Autism |
Neurology |
2025 |
Experimental Therapy |
Poland |
7,8 |
| 716 |
Cord Tissue |
Allogeneic – Unrelated |
Degenerative and traumatic cartilage damage |
Orthopedics |
2025 |
Experimental Therapy |
Poland |
25,8 |
| 717 |
Cord Tissue |
Allogeneic – Unrelated |
Autism |
Neurology |
2025 |
Experimental Therapy |
Poland |
6,8 |
| 718 |
Cord Tissue |
Allogeneic – Unrelated |
Progressive bulbar palsy |
Neurology |
2025 |
Experimental Therapy |
Poland |
62,3 |
| 719 |
Cord Tissue |
Allogeneic – Unrelated |
Encephalopathy |
Neurology |
2025 |
Experimental Therapy |
Poland |
67,2 |
| 720 |
Cord Tissue |
Allogeneic – Unrelated |
Autism |
Neurology |
2025 |
Experimental Therapy |
Poland |
7,8 |
| 721 |
Cord Tissue |
Allogeneic – Unrelated |
Degenerative and traumatic cartilage damage |
Orthopedics |
2025 |
Experimental Therapy |
Poland |
61,9 |
| 722 |
Cord Tissue |
Allogeneic – Unrelated |
Autism |
Neurology |
2025 |
Experimental Therapy |
Poland |
5,11 |
| 723 |
Cord Tissue |
Allogeneic – Unrelated |
Autism |
Neurology |
2025 |
Experimental Therapy |
Poland |
6,8 |
| 724 |
Cord Tissue |
Allogeneic – Unrelated |
Cerebral Palsy |
Neurology |
2025 |
Experimental Therapy |
Poland |
1,5 |
| 725 |
Cord Tissue |
Allogeneic – Unrelated |
Myelitis |
Neurology |
2025 |
Experimental Therapy |
Poland |
38,8 |
| 726 |
Cord Tissue |
Allogeneic – Unrelated |
Anemia |
Neurology |
2025 |
Experimental Therapy |
Poland |
3,2 |
| 727 |
Cord Tissue |
Allogeneic – Unrelated |
Autism |
Neurology |
2025 |
Experimental Therapy |
Poland |
6,8 |
| 728 |
Cord Tissue |
Allogeneic – Unrelated |
Autism |
Neurology |
2025 |
Experimental Therapy |
Poland |
7,1 |
| 729 |
Cord Tissue |
Allogeneic – Unrelated |
Spinocerebellar Ataxia |
Neurology |
2025 |
Experimental Therapy |
Poland |
5,1 |
| 730 |
Cord Tissue |
Allogeneic – Unrelated |
Cerebral Palsy |
Neurology |
2025 |
Experimental Therapy |
Poland |
1,2 |
| 731 |
Cord Tissue |
Allogeneic – Unrelated |
Cerebral Palsy |
Neurology |
2025 |
Experimental Therapy |
Poland |
1,1 |
| 732 |
Cord Tissue |
Allogeneic – Unrelated |
Autism |
Neurology |
2025 |
Experimental Therapy |
Poland |
5,11 |
| 733 |
Cord Tissue |
Allogeneic – Unrelated |
Progressive bulbar palsy |
Neurology |
2025 |
Experimental Therapy |
Poland |
63 |
| 734 |
Cord Tissue |
Allogeneic – Unrelated |
Autism |
Neurology |
2025 |
Experimental Therapy |
Poland |
15,2 |
| 735 |
Cord Tissue |
Allogeneic – Unrelated |
GvHD |
Immunology |
2025 |
Experimental Therapy |
Poland |
13 |
| 736 |
Cord Tissue |
Allogeneic – Unrelated |
Cartilage Lesions |
Orthopedics |
2025 |
Experimental Therapy |
Poland |
48,2 |
| 737 |
Cord Tissue |
Allogeneic – Unrelated |
Cartilage Lesions |
Orthopedics |
2025 |
Experimental Therapy |
Poland |
51,6 |
| 738 |
Cord Tissue |
Allogeneic – Unrelated |
GvHD |
Hematology |
2025 |
Experimental Therapy |
Poland |
12,9 |
| 739 |
Cord Tissue |
Allogeneic – Unrelated |
Autism |
Neurology |
2025 |
Experimental Therapy |
Poland |
10,1 |
| 740 |
Cord Tissue |
Allogeneic – Unrelated |
Autism |
Neurology |
2025 |
Experimental Therapy |
Poland |
8,4 |
| 741 |
Cord Tissue |
Allogeneic – Unrelated |
Cerebral Palsy |
Neurology |
2025 |
Experimental Therapy |
Poland |
3,7 |
| 742 |
Cord Tissue |
Allogeneic – Unrelated |
Cerebral Infarction |
Neurology |
2025 |
Experimental Therapy |
Poland |
57,8 |
| 743 |
Cord Tissue |
Allogeneic – Unrelated |
Autism |
Neurology |
2025 |
Experimental Therapy |
Poland |
7,7 |
| 744 |
Cord Tissue |
Allogeneic – Unrelated |
Cerebellar Syndrome |
Neurology |
2025 |
Experimental Therapy |
Poland |
43,4 |
| 745 |
Cord Tissue |
Allogeneic – Unrelated |
Cartilage Lesions |
Orthopedics |
2025 |
Experimental Therapy |
Poland |
61,1 |
| 746 |
Cord Tissue |
Allogeneic – Unrelated |
Cartilage Lesions |
Orthopedics |
2025 |
Experimental Therapy |
Poland |
57,9 |
| 747 |
Cord Tissue |
Allogeneic – Unrelated |
Cerebral Palsy |
Neurology |
2025 |
Experimental Therapy |
Poland |
1,2 |
| 748 |
Cord Tissue |
Allogeneic – Unrelated |
Cerebral Palsy |
Neurology |
2025 |
Experimental Therapy |
Poland |
7,1 |
| 749 |
Cord Tissue |
Allogeneic – Unrelated |
Autism |
Neurology |
2025 |
Experimental Therapy |
Poland |
3 |
| 750 |
Cord Blood |
Allogeneic – Related |
Thalassemia Major |
Hematology |
2025 |
Standard Therapy |
Turkey |
5,9 |
| 751 |
Cord Blood |
Autologous |
Aplastic Anemia |
Hematology |
2025 |
Standard Therapy |
Poland |
2 |
| 752 |
Cord Blood |
Allogeneic – Related |
Thalassemia Major |
Hematology |
2025 |
Standard Therapy |
Turkey |
6,8 |
| 753 |
Cord Blood |
Allogeneic – Related |
Cerebral Palsy |
Neurology |
2025 |
Experimental Therapy |
Portugal |
1 year and 8 months |
| 754 |
Cord Blood |
Autologous |
Autism |
Neurology |
2025 |
Experimental Therapy |
Romania |
5 |
| 755 |
Cord Blood |
Allogeneic |
Acute lymphoblastic leukemia |
Hematology |
2025 |
Standard Therapy |
Poland |
13 |
| 756 |
Cord Blood |
Autologous |
Autism |
Neurology |
2025 |
Experimental Therapy |
Poland |
5 ,5 |
| 757 |
Cord Blood |
Autologous |
Autism |
Neurology |
2025 |
Experimental Therapy |
Poland |
7,2 |
| 758 |
Cord Blood |
Allogeneic |
Thalassemia Major |
Hematology |
2025 |
Standard Therapy |
Turkey |
10,9 |
| 759 |
Cord Blood |
Autologous |
Autism |
Neurology |
2025 |
Experimental Therapy |
Poland |
4,1 |
| 760 |
Cord Blood |
Autologous |
Cerebral Palsy |
Neurology |
2025 |
Experimental Therapy |
Poland |
3,1 |
| 761 |
Cord Blood |
Autologous |
Autism |
Neurology |
2025 |
Experimental Therapy |
Poland |
5,2 |
| 762 |
Cord Blood |
Autologous |
Autism |
Neurology |
2025 |
Experimental Therapy |
Poland |
2,11 |
| 763 |
Cord Blood |
Autologous |
Unbalanced AVSD |
Cardiovascular |
2025 |
Experimental Therapy |
Poland |
5 months |
| 764 |
Cord Blood |
Allogeneic – Related |
Relapsed Lymphoblastic Leukemia |
Hematology |
2025 |
Standard Therapy |
Turkey |
8,5 |
| 765 |
Cord Blood |
Autologous |
Autism |
Neurology |
2025 |
Experimental Therapy |
Poland |
10,1 |
| 766 |
Cord Blood |
Autologous |
Autism |
Neurology |
2025 |
Experimental Therapy |
Poland |
5,7 |
| 767 |
Cord Blood |
Autologous |
Autism |
Neurology |
2025 |
Experimental Therapy |
Poland |
4,4 |
| 768 |
Cord Blood |
Autologous |
Autism |
Neurology |
2025 |
Experimental Therapy |
Poland |
5,5 |
| 769 |
Cord Blood |
Autologous |
Autism |
Neurology |
2025 |
Experimental Therapy |
Poland |
5,4 |
| 770 |
Cord Blood |
Autologous |
Autism |
Neurology |
2025 |
Experimental Therapy |
Poland |
3,9 |
| 771 |
Cord Blood |
Allogeneic – Related |
D57.1 Sickle Cell Anemia |
Hematology |
2025 |
Standard Therapy |
Turkey |
5 years 6 months |
| 772 |
Bone Marrow Family |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2025 |
Standard Therapy |
France |
66 |
| 773 |
Bone Marrow Family |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2025 |
Standard Therapy |
Germany |
63 |
| 774 |
Bone Marrow Family |
Allogeneic |
Myelofibrosis |
Hematology |
2025 |
Standard Therapy |
Poland |
71 |
| 775 |
Bone Marrow Family |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2025 |
Standard Therapy |
United Kingdom |
72 |
| 776 |
Bone Marrow Family |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2025 |
Standard Therapy |
France |
47 |
| 777 |
Bone Marrow Family |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2025 |
Standard Therapy |
Ukraine |
43 |
| 778 |
Bone Marrow Family |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2025 |
Standard Therapy |
Italy |
49 |
| 779 |
Bone Marrow Family |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2025 |
Standard Therapy |
France |
51 |
| 780 |
Bone Marrow Family |
Allogeneic |
Philadelphia – positive Acute Lymphoblastic Leukemia |
Hematology |
2025 |
Standard Therapy |
Germany |
61 |
| 781 |
Bone Marrow Family |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2025 |
Standard Therapy |
France |
58 |
| 782 |
Bone Marrow Family |
Allogeneic |
Myelofibrosis |
Hematology |
2025 |
Standard Therapy |
NETHERLANDS |
63 |
| 783 |
Bone Marrow Family |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2025 |
Standard Therapy |
Poland |
65 |
| 784 |
Bone Marrow Family |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2025 |
Standard Therapy |
France |
63 |
| 785 |
Bone Marrow Family |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2025 |
Standard Therapy |
Poland |
68 |
| 786 |
Bone Marrow Family |
Allogeneic |
Myelofibrosis |
Hematology |
2025 |
Standard Therapy |
France |
71 |
| 787 |
Bone Marrow Family |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2025 |
Standard Therapy |
Russia |
51 |
| 788 |
Bone Marrow Family |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2025 |
Standard Therapy |
Germany |
62 |
| 789 |
Bone Marrow Family |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2025 |
Standard Therapy |
Czechia |
54 |
| 790 |
Bone Marrow Family |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2025 |
Standard Therapy |
United Kingdom |
16 |
| 791 |
Bone Marrow Family |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2025 |
Standard Therapy |
USA |
61 |
| 792 |
Bone Marrow Family |
Allogeneic |
Chronic Myelomonocytic Leukemia |
Hematology |
2025 |
Standard Therapy |
Poland |
61 |
| 793 |
Bone Marrow Family |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2025 |
Standard Therapy |
Italy |
70 |
| 794 |
Bone Marrow Family |
Allogeneic |
PostET Myelofibrosis |
Hematology |
2025 |
Standard Therapy |
Netherlands |
21 |
| 795 |
Bone Marrow Family |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2025 |
Standard Therapy |
Poland |
68 |
| 796 |
Bone Marrow Family |
Allogeneic |
Acute Myelogenous Leukemia/ Mielodysplastic Syndrome |
Hematology |
2025 |
Standard Therapy |
Germany |
65 |
| 797 |
Bone Marrow Family |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2025 |
Standard Therapy |
NETHERLANDS |
60 |
| 798 |
Bone Marrow Family |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2025 |
Standard Therapy |
USA |
33 |
| 799 |
Bone Marrow Family |
Allogeneic |
Muscular Dystrophy Association |
Hematology |
2025 |
Standard Therapy |
United Kingdom |
75 |
| 800 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2025 |
Standard Therapy |
Germany |
72 |